Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: E9B3Q6
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 259 | 263 | PF00656 | 0.470 |
CLV_C14_Caspase3-7 | 54 | 58 | PF00656 | 0.612 |
CLV_NRD_NRD_1 | 187 | 189 | PF00675 | 0.618 |
CLV_PCSK_KEX2_1 | 185 | 187 | PF00082 | 0.644 |
CLV_PCSK_KEX2_1 | 268 | 270 | PF00082 | 0.519 |
CLV_PCSK_KEX2_1 | 301 | 303 | PF00082 | 0.567 |
CLV_PCSK_KEX2_1 | 337 | 339 | PF00082 | 0.420 |
CLV_PCSK_PC1ET2_1 | 185 | 187 | PF00082 | 0.644 |
CLV_PCSK_PC1ET2_1 | 268 | 270 | PF00082 | 0.607 |
CLV_PCSK_PC1ET2_1 | 301 | 303 | PF00082 | 0.544 |
CLV_PCSK_PC1ET2_1 | 337 | 339 | PF00082 | 0.485 |
CLV_PCSK_SKI1_1 | 342 | 346 | PF00082 | 0.475 |
DEG_APCC_DBOX_1 | 337 | 345 | PF00400 | 0.506 |
DEG_SCF_FBW7_1 | 216 | 223 | PF00400 | 0.566 |
DOC_CDC14_PxL_1 | 212 | 220 | PF14671 | 0.595 |
DOC_CYCLIN_RxL_1 | 115 | 124 | PF00134 | 0.451 |
DOC_CYCLIN_RxL_1 | 342 | 351 | PF00134 | 0.469 |
DOC_PP1_RVXF_1 | 354 | 361 | PF00149 | 0.518 |
DOC_PP2B_LxvP_1 | 120 | 123 | PF13499 | 0.490 |
DOC_PP4_FxxP_1 | 8 | 11 | PF00568 | 0.541 |
DOC_USP7_MATH_1 | 220 | 224 | PF00917 | 0.663 |
DOC_USP7_MATH_1 | 237 | 241 | PF00917 | 0.591 |
DOC_USP7_MATH_1 | 249 | 253 | PF00917 | 0.604 |
DOC_USP7_MATH_1 | 254 | 258 | PF00917 | 0.728 |
DOC_USP7_MATH_1 | 4 | 8 | PF00917 | 0.537 |
DOC_WW_Pin1_4 | 216 | 221 | PF00397 | 0.649 |
LIG_14-3-3_CanoR_1 | 59 | 69 | PF00244 | 0.501 |
LIG_APCC_ABBA_1 | 37 | 42 | PF00400 | 0.576 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.558 |
LIG_BRCT_BRCA1_1 | 155 | 159 | PF00533 | 0.385 |
LIG_eIF4E_1 | 276 | 282 | PF01652 | 0.605 |
LIG_FHA_1 | 30 | 36 | PF00498 | 0.481 |
LIG_FHA_1 | 312 | 318 | PF00498 | 0.661 |
LIG_FHA_1 | 97 | 103 | PF00498 | 0.474 |
LIG_FHA_2 | 18 | 24 | PF00498 | 0.499 |
LIG_FHA_2 | 71 | 77 | PF00498 | 0.354 |
LIG_LIR_Apic_2 | 277 | 283 | PF02991 | 0.599 |
LIG_LIR_Apic_2 | 6 | 11 | PF02991 | 0.611 |
LIG_LIR_Apic_2 | 63 | 69 | PF02991 | 0.570 |
LIG_LIR_Nem_3 | 311 | 316 | PF02991 | 0.576 |
LIG_LIR_Nem_3 | 359 | 363 | PF02991 | 0.446 |
LIG_MYND_1 | 216 | 220 | PF01753 | 0.637 |
LIG_MYND_1 | 279 | 283 | PF01753 | 0.597 |
LIG_OCRL_FandH_1 | 26 | 38 | PF00620 | 0.444 |
LIG_Pex14_1 | 66 | 70 | PF04695 | 0.457 |
LIG_SH2_STAP1 | 313 | 317 | PF00017 | 0.583 |
LIG_SH2_STAP1 | 363 | 367 | PF00017 | 0.497 |
LIG_SH2_STAP1 | 77 | 81 | PF00017 | 0.302 |
LIG_SH2_STAT3 | 316 | 319 | PF00017 | 0.522 |
LIG_SH2_STAT5 | 183 | 186 | PF00017 | 0.619 |
LIG_SH2_STAT5 | 313 | 316 | PF00017 | 0.600 |
LIG_SH2_STAT5 | 327 | 330 | PF00017 | 0.547 |
LIG_SH2_STAT5 | 70 | 73 | PF00017 | 0.362 |
LIG_SH3_1 | 201 | 207 | PF00018 | 0.573 |
LIG_SH3_3 | 120 | 126 | PF00018 | 0.479 |
LIG_SH3_3 | 201 | 207 | PF00018 | 0.573 |
LIG_SUMO_SIM_anti_2 | 91 | 96 | PF11976 | 0.454 |
LIG_TRAF2_1 | 20 | 23 | PF00917 | 0.454 |
LIG_TRAF2_1 | 303 | 306 | PF00917 | 0.579 |
LIG_UBA3_1 | 348 | 356 | PF00899 | 0.476 |
LIG_WRC_WIRS_1 | 221 | 226 | PF05994 | 0.572 |
LIG_WW_2 | 204 | 207 | PF00397 | 0.567 |
MOD_CK1_1 | 311 | 317 | PF00069 | 0.544 |
MOD_CK1_1 | 52 | 58 | PF00069 | 0.632 |
MOD_CK2_1 | 17 | 23 | PF00069 | 0.516 |
MOD_GlcNHglycan | 127 | 130 | PF01048 | 0.475 |
MOD_GlcNHglycan | 137 | 140 | PF01048 | 0.488 |
MOD_GlcNHglycan | 178 | 181 | PF01048 | 0.598 |
MOD_GlcNHglycan | 229 | 232 | PF01048 | 0.651 |
MOD_GlcNHglycan | 234 | 237 | PF01048 | 0.677 |
MOD_GlcNHglycan | 239 | 242 | PF01048 | 0.695 |
MOD_GlcNHglycan | 258 | 261 | PF01048 | 0.664 |
MOD_GlcNHglycan | 51 | 54 | PF01048 | 0.624 |
MOD_GSK3_1 | 216 | 223 | PF00069 | 0.717 |
MOD_GSK3_1 | 227 | 234 | PF00069 | 0.607 |
MOD_LATS_1 | 15 | 21 | PF00433 | 0.436 |
MOD_N-GLC_1 | 274 | 279 | PF02516 | 0.604 |
MOD_N-GLC_1 | 49 | 54 | PF02516 | 0.618 |
MOD_N-GLC_1 | 95 | 100 | PF02516 | 0.467 |
MOD_NEK2_1 | 134 | 139 | PF00069 | 0.460 |
MOD_NEK2_1 | 232 | 237 | PF00069 | 0.607 |
MOD_NEK2_1 | 274 | 279 | PF00069 | 0.596 |
MOD_NEK2_1 | 29 | 34 | PF00069 | 0.461 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.373 |
MOD_PIKK_1 | 10 | 16 | PF00454 | 0.678 |
MOD_PIKK_1 | 101 | 107 | PF00454 | 0.483 |
MOD_PIKK_1 | 153 | 159 | PF00454 | 0.378 |
MOD_PKA_2 | 29 | 35 | PF00069 | 0.575 |
MOD_PKA_2 | 308 | 314 | PF00069 | 0.588 |
MOD_PKA_2 | 365 | 371 | PF00069 | 0.332 |
MOD_PKA_2 | 58 | 64 | PF00069 | 0.699 |
MOD_Plk_1 | 249 | 255 | PF00069 | 0.618 |
MOD_Plk_1 | 90 | 96 | PF00069 | 0.355 |
MOD_Plk_4 | 90 | 96 | PF00069 | 0.448 |
MOD_ProDKin_1 | 216 | 222 | PF00069 | 0.649 |
MOD_SUMO_rev_2 | 284 | 293 | PF00179 | 0.555 |
MOD_SUMO_rev_2 | 351 | 358 | PF00179 | 0.520 |
TRG_DiLeu_BaEn_3 | 22 | 28 | PF01217 | 0.417 |
TRG_DiLeu_BaLyEn_6 | 98 | 103 | PF01217 | 0.473 |
TRG_ER_diArg_1 | 186 | 188 | PF00400 | 0.621 |
TRG_NES_CRM1_1 | 339 | 351 | PF08389 | 0.501 |
TRG_NLS_MonoCore_2 | 184 | 189 | PF00514 | 0.614 |
TRG_NLS_MonoExtC_3 | 184 | 190 | PF00514 | 0.639 |
TRG_NLS_MonoExtC_3 | 267 | 272 | PF00514 | 0.568 |
TRG_NLS_MonoExtN_4 | 182 | 189 | PF00514 | 0.628 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3S6 | Leptomonas seymouri | 58% | 97% |
A0A3Q8IK00 | Leishmania donovani | 91% | 99% |
A0A422P2K1 | Trypanosoma rangeli | 37% | 100% |
A4HLB4 | Leishmania braziliensis | 80% | 100% |
A4I8U0 | Leishmania infantum | 91% | 99% |
Q4Q4D1 | Leishmania major | 91% | 100% |
V5AZW9 | Trypanosoma cruzi | 34% | 100% |